Antioxidants and CVD in diabetes: Where do we stand now?

被引：27
|
作者：
Yim S. [1 ]
Malhotra A. [1 ]
Veves A. [1 ]
机构：
[1] Microcirculation Laboratory, Palmer 321A, Beth Israel Deaconess Medical Center, Boston, MA 02215, One Deaconess Road
来源：
Current Diabetes Reports | 2007年 / 7卷 / 1期
基金：
美国国家卫生研究院;
关键词：
Endothelial Dysfunction; Physiol Heart Circ; Polyol Pathway; Benfotiamine; Smooth Muscle Cell Growth;
D O I：
10.1007/s11892-007-0003-9
中图分类号：
学科分类号：
摘要：
Diabetes is an oxidative stress disorder as a result of both hyperglycemia and increased levels of free fatty acids. Oxidative stress has been implicated in the pathogenesis of diabetes-related complications, and treatment with antioxidants seemed to be a promising therapeutic option. Although animal studies and preliminary human studies were initially encouraging, subsequent human studies have failed to show a clear benefit of antioxidants, whereas some studies have even suggested that they can be potentially harmful. Therefore, treatment with antioxidants cannot be currently recommended as a therapeutic option. Copyright © 2007 by Current Medicine Group LLC.
引用
收藏
页码：8 / 13
页数：5
相关论文
共 50 条
  • [41] POLYCHLORINATED-BIPHENYLS - WHERE DO WE STAND NOW
    JONES, GRN
    LANCET, 1989, 2 (8666): : 791 - 794
  • [42] Diabetes research and diabetes care - Where do we stand?
    Davidson, MB
    DIABETES CARE, 1998, 21 (12) : 2152 - 2160
  • [43] Quality assessment in surgery: where do we stand now and where should we be heading?
    Weyers, S.
    Van Calenbergh, S.
    Van Nieuwenhove, Y.
    Mestdagh, G.
    Coppens, M.
    Bosteels, J.
    GYNECOLOGICAL SURGERY, 2014, 11 (02) : 89 - 95
  • [44] Vitamin D and diabetes: Where do we stand?
    Mathieu, Chantal
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 108 (02) : 201 - 209
  • [45] Vaccine for Diabetes-Where Do We Stand?
    Chellappan, Dinesh Kumar
    Bhandare, Richie R.
    Shaik, Afzal B.
    Prasad, Krishna
    Suhaimi, Nurfatihah Azlyna Ahmad
    Yap, Wei Sheng
    Das, Arpita
    Banerjee, Pradipta
    Ghosh, Nandini
    Guith, Tanner
    Das, Amitava
    Balakrishnan, Sarannya
    Candasamy, Mayuren
    Mayuren, Jayashree
    Palaniveloo, Kishneth
    Gupta, Gaurav
    Singh, Sachin Kumar
    Dua, Kamal
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)
  • [46] Precision diabetes: Where do we stand today?
    Mohan, Viswanathan
    Unnikrishnan, Ranjit
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2018, 148 (05) : 472 - 475
  • [47] Aspirin for primary prevention of CVD in CKD: where do we stand?
    Gallagher, Hugh
    Lown, Mark
    Fuat, Ahmet
    Roderick, Paul
    BRITISH JOURNAL OF GENERAL PRACTICE, 2019, 69 (689): : 590 - 591
  • [48] Suicide gene therapy in cancer: Where do we stand now?
    Duarte, Sonia
    Carle, Georges
    Faneca, Henrique
    Pedroso de Lima, Maria C.
    Pierrefite-Carle, Valerie
    CANCER LETTERS, 2012, 324 (02) : 160 - 170
  • [49] Orally active insulin mimics: where do we stand now?
    M. Balasubramanyam
    V. Mohan
    Journal of Biosciences, 2001, 26 : 383 - 390
  • [50] Viscoelastic tests in liver disease: where do we stand now?
    Alina Buliarca
    Adelina Horhat
    Tudor Mocan
    Rares Craciun
    Bogdan Procopet
    Zeno Sparchez
    World Journal of Gastroenterology, 2021, 27 (23) : 3290 - 3302
12345